Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent
1994-01-25
1994-12-27
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Lymphokine
Interleukin
514 2, 514 21, A61K 3702, C07G 700
Patent
active
053763688
ABSTRACT:
A method for treatment of inflammation, comprising the step of administering to a patient in need thereof an effective, inflammation-inhibiting amount of a composition comprising IL-6, or IL-6 and TGF.beta. together in a weight ratio of from about 5:95 to 95:5, preferably from about 20:80 to 80:20. Also disclosed is a composition for treatment of inflammation, comprising as active ingredients IL-6 and TGF.beta. in a weight ratio of from about 5:95 to about 95:5, optionally comprising a carrier in combination with the active ingredients, and a method of reducing migration of neutrophils into tissue of an animal which has received an inflammatory stimulus, comprising the step of administering to the tissue an effective neutrophil-migration-inhibiting amount of a composition as defined above.
REFERENCES:
patent: 4806523 (1989-02-01), Bentz et al.
patent: 4971952 (1990-11-01), Bentz et al.
patent: 4973478 (1990-11-01), Gauldie et al.
patent: 4975467 (1990-12-01), Ku et al.
patent: 5300292 (1994-04-01), Ulich
Aderka, et al. J. of Immunology 143 (11): 3517-3523 (1989).
Dunham et al. J. of Leukocyte Biology 48: 473-481 (1990).
Ulich et al. J. of Immunology 146 (7): 2316-2323 (1991).
Ulich et al. Amer. J. of Pathology 137 (5): 1173-1185 (1990).
Blaug, Medicated Applications, "Remington's Pharmaceutical Sciences", Chapter 87: 1523-1553.
Hirano et al. Nature 324 (6): 73-76 (1986).
Castell et al. Eur. J. Biochem. 177: 357-361 (1988).
Northemann et al. J. of Biological Chem. 264 (27): 16072-16082 (1989).
Barton et al. Protective Role of Inrterleukin 6 in the Lipopolysaccharide-Galactosamine Septic Shock Model, Infection and Immunity: 1496-1499 (1993).
Tilg et al. Interleukin-6 (IL-6) As an Anti-Inflammatory Cytokine: Induction of Circulating IL-1 Receptor Antagonist and Soluble Tumor Necrosis Factor Receptor p55, Blood. 83: 113-118 (1994).
Regents of University of California
Schain Howard E.
Touzeau P. Lynn
LandOfFree
Composition and method for treating inflammation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method for treating inflammation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for treating inflammation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-917324